Aceclofenac Dosing in Children
Aceclofenac is not established for use in children under 6 years of age, and there is insufficient evidence to recommend specific dosing for the pediatric population. 1
Current Evidence and Limitations
The FDA drug label explicitly states that "the dosage and indication is not established yet for children with less than 6 years old" 1. This represents the most authoritative guidance available, and no pediatric-specific dosing guidelines exist in the medical literature provided.
Adult Dosing for Reference
For adults, the recommended dose is 200 mg daily taken as a single dose every 24 hours 1. However, this cannot be extrapolated to children without appropriate pharmacokinetic and safety data.
Clinical Considerations
Why Pediatric Data is Critical
- Pharmacokinetic differences: Children have different drug metabolism, clearance rates, and volumes of distribution compared to adults. Studies with other NSAIDs (like diclofenac and ibuprofen) demonstrate that children aged 3 months to 2.5 years show increased clearance and volume of distribution, potentially requiring higher weight-based dosing 2
- Safety concerns: NSAIDs carry risks of gastrointestinal, renal, and cardiovascular adverse effects that may manifest differently in children
Contraindications Apply to All Ages
Even if considering off-label use in older children, aceclofenac is contraindicated in patients with:
- Allergy to aceclofenac, diclofenac, or other NSAIDs
- Asthma (may precipitate attacks)
- Active peptic ulcer disease 1
Alternative Approaches
For pediatric musculoskeletal pain and inflammation, consider evidence-based alternatives:
- Ibuprofen: Well-studied in children with established weight-based dosing
- Acetaminophen/Paracetamol: First-line for fever and mild-to-moderate pain with superior tolerability profile 2
- Other NSAIDs with established pediatric safety data (diclofenac, naproxen) for inflammatory conditions like juvenile idiopathic arthritis
Common Pitfall
Do not attempt weight-based extrapolation from adult doses without pharmacokinetic data—this approach has been shown to result in inappropriate dosing in pediatric populations 3
The absence of established pediatric dosing for aceclofenac means it should not be used in children when safer, evidence-based alternatives are available.